Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

In addition, the Company has granted Aegis Capital Corp. a 45-day option to purchase additional shares of Common Stock and/or Common Warrants, representing up to 15% of the number of securities sold in the offering, solely to cover over-allotments, if any. The securities described above were offered pursuant to a registration statement on Form S-1 (File No. 333- 280253) originally filed with the Securities and Exchange Commission ("SEC") on June 17, 2024, as amended, and which registration statement became ...